Homepage Rhodia

Third quarter 2008 results

Third quarter 2008 results

News release

Paris, November 6, 2008

PDF version

Third quarter 2008 results

Rhodia confirms its strong pricing power

and full year objectives

Key highlights

· Another quarter of strong pricing power: +14% fully offsetting record raw material and energy inflation as well as a negative forex impact

· Good level of demand across businesses compensating for first signs of slowdown in Polyamide

· Recurring EBITDA(1) at €168 million driven by strong performance in Novecare, Silcea, Eco Services and Acetow

· Net Profit Group Share up 24% year-on-year to €56 million

· Net Debt reduction reflecting completion of Isocyanates divestment

· Long-dated maturity financial resources

· Confirmation of 2008 guidance

“In the third quarter, Rhodia confirmed once again its strong pricing power which allowed the Group to offset not only record raw material and energy cost increases, but also the negative foreign exchange impact," commented Rhodia Chairman and Chief Executive Officer Jean-Pierre Clamadieu.

We are continuously deliveringon our commitments.Our leading competitive positions supported by our focused portfolio strategy, our balanced geographical presence, the diversity of the markets we serve and our healthy financials, give us confidence in the potential of our businesses going forward. We therefore confirm our 2008 financial objectives."

Summary income statement

In € million

Q3 2007

Q3 2007


like for like(2)

Q3 2008

Variation


like for like(2)

Net Sales

1,187

1,152

1,224

6,3%

Recurring EBITDA(1)

179

174

168

(3.4)%

Operating Profit

105

104

87

(16.3)%

Profit from continuing operations

36

22

Profit/(loss) from discontinued operations

8

34

Net Profit/ Group Share

45

56

Earnings per Share (in €)

0.44

0.55

Free Cash Flow(3)

58

(69)

(1) Before restructuring and other operating income and expenses

(2) Like for like: at constant scope and currency conversion

(3) Defined as “net cash provided by operating activities” before margin call plus “non recurring refinancing cash costs” minus Capital Expenditure




1. Strong pricing fully offset cost rises and negative transactional forex impact

Net Sales rose by 6.3%(1) to €1,224 million, driven by a 13.7% positive impact from price increases in local currencies. A sustained good level of demand was registered across businesses compensating for first signs of slowdown in Polyamide. As anticipated, volumes were also affected by Q3-Q4 CER phasing. The transactional foreign exchange impact was (2.6)%.

RecurringEBITDA(1) stood at €168 million versus €174 million in Q3 2007. The (3.4)% decline was mainly due to volume phasing impact of CERs, while negative effect from lower volumes in Polyamide were mostly offset by good performance in other Enterprises, particularly Novecare. Price increases of €158 million fully offset both a €(139) million increase in raw material and energy costs as well as a transactional foreign exchange impact of €(17) million. Fixed costs were under control and decreased by €9 million.

Operating Profit(1) amounted to €87 million versus €104 million in the third quarter of 2007, essentially reflecting the change in recurring EBITDA.

The Financial Result was stable at €(44) million compared to the third quarter 2007.

The Net Profit Group Share increased 24% from €45 million in the third quarter of 2007 to €56 million in the third quarter of 2008, reflecting the capital gains from the Isocyanates divestment.

Earnings per Share rose 25% to €0.55 from €0.44 a year earlier.

(1) Like for like: at constant scope and currency conversion

2.Free Cash Flow affected by temporarily negative Working Capital variance

Working Capital stood at 14.6% of total sales versus 13.6% a year earlier. The €87 million increase in Working Capital versus the end of the second quarter of 2008 can be attributed to the strong price rises impacting both receivables and inventories, as well as the continued effect of the deployment of the SAP based system in Rhodia’s USA operations which should be normalized by end of 2008.

Due to the continuous selective investment policy, Capital Expenditure decreased from €83 million in the third quarter of 2007 to €71 million in the third quarter of 2008.

The temporary increase in Working Capital weighed on the Free Cash Flow, which amounted to

€(69) million.

Consolidated Net Debt decreased to €1,451 million on September 30, 2008 versus €1,570 million on June 30, 2008, benefiting from €224 million of proceeds from divestments completed in the third quarter of 2008.

3. Overview by Enterprise

Polyamide

Rhodia Polyamide serves the automotive, electricals, electronic components, sportswear and leisure markets. Its expertise in the polyamide chain has allowed it to develop activities upstream in intermediates and polymers and downstream in engineering plastics.

In € million

Q3 2007

Q3 2007

Like for like

Q3 2008

Net Sales

494

482

465

Recurring EBITDA

68

68

38

Rhodia Polyamide continued its price-over-volume strategy. While volumes in Europe were impacted by the slowdown in the automotive and textile markets, the Enterprise implemented further price increase initiatives: those offset close to 90 % of rises in raw material and energy costs, in particular for Butadiene. US competitors holding available volumes due to the slowdown in their domestic market benefited from favorable currency and natural gas costs.

The decline in the US Dollar against the Brazilian Real and the Euro led to a negative transactional forex impact of €(11) million year-on-year.

In October, Rhodia Polyamide launched plans to optimize its European production and research & development resources, as first step of a broader program aimed at cutting costs by about €40 million per year by 2010.

Novecare

Rhodia Novecare provides high-performance products and solutions to a wide range of industries including cosmetics, detergents, agrochemicals and oil, as well as industrial applications.

In € million

Q3 2007

Q3 2007

Like for like

Q3 2008

Net Sales

227

211

260

Recurring EBITDA

25

22

43

Rhodia Novecare, nearly doubled its EBITDA year-on-year. This record quarter reflects the Enterprise’s reinforced pricing power and a strong growth momentum in the oilfield and agro markets.

Silcea

Rhodia Silcea produces high performance silicas, rare earth-based materials and diphenols to serve the automotive emissions reduction, tire, lighting, electronics, flavours & fragrances markets.

In € million

Q3 2007

Q3 2007

Like for like

Q3 2008

Net Sales

179

176

193

Recurring EBITDA

33

31

30

Rhodia Silcea registered overall good volumes. This was particularly true for silicas for low rolling resistance tires. The Enterprise demonstrated that its pricing power could offset most raw material and energy cost increases.

Silcea was impacted by a €(2) million negative transactional forex effect.

Energy Services

Rhodia Energy Services is in charge of the Group’s energy supply and the management of Rhodia’s projects related to the reduction of greenhouse gas emissions.

In € million

Q3 2007

Q3 2007

Like for like

Q3 2008

Net Sales

60

60

43

Recurring EBITDA

41

42

35

Carbon Emission Reduction (CER) sales reflected the expected Q3-Q4 phasing. Recurring EBITDA of €28 million was generated from CERs, versus €39 million in the third quarter of 2007.

The cogeneration business is traditionally slow in the third quarter.

Rhodia expects to generate slightly more than 13 million tons of CERs for the full year 2008.



Acetow

Rhodia Acetow is a global producer of filter tow, mainly used for making cigarette filters.

In € million

Q3 2007

Q3 2007

Like for like

Q3 2008

Net Sales

112

110

112

Recurring EBITDA

20

21

20

Rhodia Acetow was able to increase its selling prices and thus, offset rises in raw material and energy costs.

Acetow confirms its target to decrease its forex transactional exposure by 50 % by the end of 2008.

The Enterprise’s ongoing cost competitiveness program, launched in the fourth quarter of 2007, has also started to record progress.

Eco Services

Rhodia Eco Services offers sulphuric acid regeneration services to chemical manufacturers and oil refiners in North America.

In € million

Q3 2007

Q3 2007

Like for like

Q3 2008

Net Sales

57

52

90

Recurring EBITDA

22

19

19

Rhodia Eco Services enjoyed good pricing power. This allowed the Enterprise to offset the €(5) million impact on EBITDA resulting from the hurricanes in the USA. The non cash negative forex conversion impact amounted to €(3) million.

In the coming months, Rhodia Eco Services’ strong pricing power should continue.

4. Outlook

The Group is pro-actively adjusting to the challenging economic environment with aggressive cost competitiveness plans and a strong focus on cash management.

Combined with those actions, its performance year-to-date and the proven resilience of its portfolio allow the Group to confirm its 2008 full year objectives:

· Recurring EBITDA should be within 5% of the level achieved in 2007

· Earnings per Share should increase versus 2007

· Net Debt should be further reduced compared to the end of 2007, supported by a solid Free Cash Flow generation in the fourth quarter of 2008.

After the massive impact of raw material and energy inflation as well as adverse currency fluctuations on the Group’s EBITDA over the last nine months, Rhodia is observing a favorable inflexion point at the end of the third quarter 2008. This structurally positive effect should gradually materialize in the Group’s accounts, starting early 2009.

Safe Harbor for forward looking statements

This press release contains elements that are not historical facts including, without limitation, certain statements on future expectations and other forward-looking statements. Such statements are based on management’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those anticipated.



Rhodiais an international chemical company resolutely committed to sustainable development.As a leader in its businesses, the Group aims to improve its customers’ performance through the pursuit of operational excellence and its ability to innovate. Structured around six Enterprises, Rhodia is the partner of major players in the automotive, tire, electronics, perfume, health & beauty and home care markets.The Group employs around 15,000 people worldwide and generated sales of €4.8billion in 2007.Rhodia is listed on Euronext Paris.

Upcoming events

Rhodia’s fourth quarter and annual 2008 results will be published onFebruary 25, 2009.

Contacts

Media Relations

Rita Hillig +33 (0)1 53 56 64 04

Lamia Narcisse +33 (0)1 53 56 59 62



Investor Relations

Maria Alcon +33 (0)1 53 56 64 89

Loic Harrari +33 (0)1 53 56 64 80



Results Fact Sheet : Q3 & YTD Sept '08

Income Statement

€ million

Q3*

‘07

Q3*

‘08

Variation

YTD

Sept*

‘07

YTD

Sept*

‘08

Variation

Net Sales

1,187

1,224

3.1%

3,595

3,637

1.2%

Other revenue

83

122

318

380

Recurring EBITDA

179

168

(6.1)%

571

523

(8.4)%

Recurring EBITDA Margin(1)

15.1%

13.7%

15.9%

14.4%

Depreciation & Amortization

excl. Amos restr

(71)

(79)

(208)

(218)

Other Gains and Losses

3

(2)

10

(4)

Restructuring Costs

(6)

-

(28)

(6)

Operating Profit

105

87

(17.1)%

345

295

(14.5)%

Financial Results

(44)

(44)

(246)

(142)

Share of profit (loss) of associates

-

-

-

1

Profit/(loss) before income tax

61

43

(29.5)%

99

154

55.6%

Income tax

(25)

(21)

(75)

(58)

Profit/(loss)



from continuing operations

36

22

24

96

Profit/(loss)

from discontinued operations

8

34

84

38

Net Profit/(loss)

44

56

108

134

Net Profit/(loss) (Group Share)

45

56

24.4%

107

133

24.3%

Earnings per share €

0.44

0.55

1.06

1.31

Average number of shares outstanding

100,361,373

101,087,068

100,353,883

101,027,219

(1) Recurring EBITDA margin excluding CERs 11.8% vs 12.4% in Q3 ‘07 and 12.1% vs 13.6% in YTD Sept ‘07

Net Sales

Recurring EBITDA

Operating Profit

€ million

Q3* ‘07

Q3* ‘08

Variation

Q3* ‘07

Q3* ‘08

Variation

Q3* ‘07

Q3* ‘08

RHODIA

1,187

1,224

3.1%

179

168

(6.1)%

105

87

POLYAMIDE

494

465

(5.9)%

68

38

(44.1)%

43

11

NOVECARE

227

260

14.5%

25

43

72.0%

14

31

SILCEA

179

193

7.8%

33

30

(9.1)%

20

19

ENERGY SERVICES

60

43

(28.3)%

41

35

(14.6)%

40

27

ACETOW

112

112

-

20

20

-

13

12

ECO SERVICES

57

90

57.9%

22

19

(13.6)%

18

16

CORPORATE & Others

58(1)

61(1)

5.2%

(30)

(17)

43.3%

(43)

(29)

Net Sales

Recurring EBITDA

Operating Profit

€ million

YTD* Sept ‘07

YTD* Sept ‘08

Variation

YTD* Sept ‘07

YTD* Sept ‘08

Variation

YTD* Sept ‘07

YTD* Sept ‘08

RHODIA

3,595

3,637

1.2%

571

523

(8.4)%

345

295

POLYAMIDE

1,484

1,436

(3.2)%

210

150

(28.6)%

111

74

NOVECARE

717

735

2.5%

88

101

14.8%

60

71

SILCEA

547

577

5.5%

109

92

(15.6)%

77

60

ENERGY SERVICES

144

147

2.1%

124

126

1.6%

117

113

ACETOW

327

338

3.4%

62

57

(8.1)%

40

35

ECO SERVICES

165

217

31.5%

58

52

(10.3)%

46

42

CORPORATE & Others

211(1)

187(1)

(11.4)%

(80)

(55)

31.3%

(106)

(100)

(1) including intercompany sales elimination

Net Financial Debt

December 31, 2007

June 30, 2008

September 30, 2008

1,484

1,570

1,451

Confirmation of 2008 objectives

  • Recurring EBITDA within 5% of 2007 level

  • EPS increase YoY

  • Further reduction in Net Debt vs year-end ’07, supported by solid Free Cash Flow generation in Q4

* Unaudited



Results Fact Sheet : Q3 ‘08

Enterprise

POLYAMIDE

"Price over Volume" strategy maintained

Further price increases effectively compensating for continued raw material cost increases

Volumes impacted by slowdown in auto and textile / fibers markets, particularly inEurope

Significant €(11)m net transaction forex impact

Competitiveness enhancement plans launched

NOVECARE

Record quarter with EBITDA almost doubled like for like:

Reinforced pricing power

Strong growth momentum in oilfield and agro markets

SILCEA

Confirmation of good volume overall, including automotive tire market driven by ongoing substitution

Proven pricing power offsetting most raw material and energy cost increases

€(2)m negative net transaction forex impact

ENERGY SERVICES

Volumes reflecting Q3-Q4 CERs sales phasing as anticipated

€28m rec. EBITDA generated from CERs vs €39m in Q3 ‘07

International Transaction Log (ITL) successfully implemented in October

Full year volume expectations slightly over 13mT

ACETOW

Raw material cost inflation successfully compensated for by selling price increases

On track with plan to decrease by 50% forex (transaction) exposure by the end of the year

Initial progress in cost competitiveness program

ECO SERVICES

Good pricing power allowing to offset raw material rises as well as the €(5)m EBITDA impact from US hurricanes

€(3)m negative non-cash forex conversion

€ million

Net Sales

Q3* ‘07

Scope

Foreign
Exchange
conversion

Net Sales Q3* ‘07 like for like

Foreign Exchange transaction

Volume & mix

Selling Price

Net Sales

Q3* ‘08

Variation Q3 ’08 -Q3 ‘07

Variation Q3* ‘08 – Q3* ‘07 like for like

RHODIA

1,187

(3)

(32)

1,152

(30)

(56)

158

1,224

3.1%

6.3%

POLYAMIDE

494

(7)

(5)

482

(21)

(35)

39

465

(5.9)%

(3.5)%

NOVECARE

227

(2)

(14)

211

0

5

44

260

14.5%

23.2%

SILCEA

179

2

(5)

176

(2)

4

15

193

7.8%

9.7%

ENERGY

SERVICES

60

0

0

60

0

(20)

3

43

(28.3)%

(28.3)%

ACETOW

112

0

(2)

110

(6)

0

8

112

0.0%

1.8%

ECO SERVICES

57

0

(5)

52

0

(4)

42

90

57.9%

73.1%

CORPORATE

& Others

including intercompany
sales elimination

58

4

(1)

61

(1)

(6)

7

61

5.2%

0.0%

€ million

Rec. EBITDA

Q3*

‘07

Scope

Forex conversion

Rec. EBITDA

Q3*

‘07

like for like

Volume & mix

Selling
Price

Raw materials

& Energy

Forex transaction

Fixed
Costs

Rec. EBITDA

Q3*

‘08

Rec. EBITDA Margin

Q3*

‘08

RHODIA

179

0

(5)

174

(17)

158

(139)

(17)

9

168

13.7%

POLYAMIDE

68

0

0

68

(9)

39

(44)

(11)

(5)

38

8.2%

NOVECARE

25

(1)

(2)

22

6

44

(30)

1

0

43

16.5%

SILCEA

33

(1)

(1)

31

3

15

(19)

(2)

2

30

15.5%

ENERGY

SERVICES

41

1

0

42

(11)

3

2

0

(1)

35

n.m.

ACETOW

20

0

1

21

0

8

(7)

(3)

1

20

17.9%

ECO SERVICES

22

0

(3)

19

(3)

42

(36)

0

(3)

19

21.1%

CORPORATE

& Others

(30)

1

0

(29)

(3)

7

(5)

(2)

15

(17)

n.m.

* Unaudited

Results Fact Sheet : YTD Sept ‘08

€ million

Net Sales

YTD* Sept ‘07

Scope

Foreign
Exchange
conversion

Net Sales YTD* Sept ‘07 like for like

Foreign Exchange transaction

Volume & mix

Selling Price

Net Sales

YTD* Sept ‘08

Variation YTD

Sept ‘08- YTD*

Sept ‘07

Variation YTD*

Sept ‘08 – YTD*

Sept ‘07 like for like

RHODIA

3,595

(4)

(127)

3,464

(110)

(25)

308

3,637

1.2%

5.0%

POLYAMIDE

1,484

(10)

(18)

1,456

(75)

(14)

69

1,436

(3.2)%

(1.4)%

NOVECARE

717

(3)

(56)

658

(1)

2

76

735

2.5%

11.7%

SILCEA

547

12

(24)

535

(8)

13

37

577

5.5%

7.9%

ENERGY

SERVICES

144

0

0

144

0

(9)

12

147

2.1%

2.1%

ACETOW

327

0

(7)

320

(23)

18

23

338

3.4%

5.6%

ECO SERVICES

165

0

(19)

146

0

(5)

76

217

31.5%

48.6%

CORPORATE

& Others
including intercompany
sales elimination

211

(3)

(3)

205

(3)

(30)

15

187

(11.4)%

(8.8)%

€ million

Rec. EBITDA

YTD* Sept ‘07

Scope

Forex conversion

Rec. EBITDA

YTD* Sept ‘07

like for like

Volume & mix

Selling
Price

Raw materials

& Energy

Forex transaction

Fixed
Costs

Rec. EBITDA

YTD* Sept ‘08

Rec. EBITDA Margin

YTD*

Sept ‘08

RHODIA

571

(1)

(22)

548

(8)

308

(274)

(59)

8

523

14.4%

POLYAMIDE

210

(1)

(1)

208

(6)

69

(78)

(36)

(7)

150

10.4%

NOVECARE

88

0

(11)

77

8

76

(55)

0

(5)

101

13.7%

SILCEA

109

1

(5)

105

0

37

(43)

(7)

0

92

15.9%

ENERGY

SERVICES

124

2

0

126

(1)

12

(2)

0

(9)

126

n.m.

ACETOW

62

1

0

63

5

23

(21)

(13)

0

57

16.9%

ECO SERVICES

58

0

(9)

49

(2)

76

(65)

0

(6)

52

24.0%

CORPORATE

& Others

(80)

(4)

4

(80)

(12)

15

(10)

(3)

35

(55)

n.m.

* Unaudited



Results Fact Sheet : Quarterly results

€m

Q1* ‘07

Q1* ‘08

Q2* ‘07

Q2* ‘08

H1** ‘07

H1** ‘08

Q3* ‘07

Q3* ‘08

Q4* ‘07

H2* ‘07

FY* ‘07

RHODIA

Net Sales

1,186

1,186

1,222

1,227

2,408

2,413

1,187

1,224

1,186

2,373

4,781

Recurring EBITDA

196

168

196

187

392

355

179

168

187

366

758

Rec. EBITDA margin

16.5%

14.2%

16.0%

15.2%

16.3%

14.7%

15.1%

13.7%

15.8%

15.4%

15.9%

Operating Profit

125

93

115

115

240

208

105

87

77

182

422

POLYAMIDE

Net Sales

481

476

509

495

990

971

494

465

491

985

1,975

Recurring EBITDA

67

52

75

60

142

112

68

38

70

138

280

Rec. EBITDA margin

13.9%

10.9%

14.7%

12.1%

14.3%

11.5%

13.8%

8.2%

14.3%

14.0%

14.2%

Operating Profit

42

29

26

34

68

63

43

11

45

88

156

NOVECARE

Net Sales

243

235

247

240

490

475

227

260

214

441

931

Recurring EBITDA

30

28

33

30

63

58

25

43

21

46

109

Rec. EBITDA margin

12.3%

11.9%

13.4%

12.5%

12.9%

12.2%

11.0%

16.5%

9.8%

10.4%

11.7%

Operating Profit

23

19

23

21

46

40

14

31

11

25

71

SILCEA

Net Sales

185

189

183

195

368

384

179

193

189

368

736

Recurring EBITDA

36

27

40

35

76

62

33

30

29

62

138

Rec. EBITDA margin

19.5%

14.3%

21.9%

17.9%

20.7%

16.1%

18.4%

15.5%

15.3%

16.8%

18.8%

Operating Profit

26

16

31

25

57

41

20

19

16

36

93

ENERGY SERVICES

Net Sales

43

52

41

52

84

104

60

43

58

118

202

Recurring EBITDA

52

53

31

38

83

91

41

35

57

98

181

Operating Profit

47

50

30

36

77

86

40

27

48

88

165

ACETOW

Net Sales

102

113

113

113

215

226

112

112

114

226

441

Recurring EBITDA

20

20

22

17

42

37

20

20

21

41

83

Rec. EBITDA margin

19.6%

17.7%

19.5%

15.0%

19.5%

16.4%

17.9%

17.9%

18.4%

18.1%

18.8%

Operating Profit

12

13

15

10

27

23

13

12

2

15

42

ECO SERVICES

Net Sales

52

57

56

70

108

127

57

90

53

110

218

Recurring EBITDA

14

13

22

20

36

33

22

19

12

34

70

Rec. EBITDA margin

26.9%

22.8%

39.3%

28.6%

33.3%

26.0%

38.6%

21.1%

22.6%

30.9%

32.1%

Operating Profit

10

9

18

17

28

26

18

16

8

26

54

CORPORATE & OTHERS

Sales & intercompany sales eliminations

80

64

73

62

153

126

58

61

67

125

278

Recurring EBITDA

(23)

(25)

(27)

(13)

(50)

(38)

(30)

(17)

(23)

(53)

(103)

Operating Profit

(35)

(43)

(28)

(28)

(63)

(71)

(43)

(29)

(53)

(96)

(159)

* Unaudited

** Reviewed by auditors



Consolidated income statements as of September 30, 2008

(in millions of euros)

Quarter ended September 30, (*)

Nine months ended September 30, (*)

2008

2007

2008

2007

Net sales

1,224

1,187

3,637

3,595

Other revenue

122

83

380

318

Cost of sales

(1,124)

(1,017)

(3,286)

(3,101)

Administrative and selling expenses

(118)

(124)

(374)

(384)

Research and development expenditure

(15)

(21)

(52)

(65)

Restructuring costs

-

(6)

(6)

(28)

Other operating income / (expenses)

(2)

3

(4)

10

Operating profit/(loss)

87

105

295

345

Finance income

20

37

90

103

Finance costs

(66)

(79)

(236)

(348)

Foreign exchange gains/(losses)

2

(2)

4

(1)

Share of profit/(loss) of associates

-

-

1

-

Profit/(loss) before income tax

43

61

154

99

Income tax expense

(21)

(25)

(58)

(75)

Profit/(loss) from continuing operations

22

36

96

24

Profit/(loss) from discontinued operations

34

8

38

84

Net profit for the period

56

44

134

108

Attributable to:

Equity holders of Rhodia S.A.

56

45

133

107

Minority interests

-

(1)

1

1

Earnings per share (in euros)

Continuing and discontinued operations

- Basic

- Diluted

0.55

0.54

0.44

0.44

1.31

1.30

1.06

1.06

Continuing operations

- Basic

- Diluted

0.21

0.21

0.39

0.38

0.94

0.93

0.25

0.25

Weighted average number of shares before dilution

101,087,068

100,361,373

101,027,219

100,353,883

Weighted average number of shares after dilution

102,220,450

101,474,774

101,866,560

101,525,667

* Unaudited



Consolidated balance sheets as of September 30, 2008

Assets

(in millions of euros)

AtSeptember 30, 2008(*)

AtDecember 31, 2007

Property, plant & equipment

1,546

1,686

Goodwill

203

207

Other intangible assets

206

183

Investments in associates

14

13

Other non-current financial assets

98

113

Deferred tax assets

158

161

Non-current assets

2,225

2,363

Inventories

729

583

Income tax receivable

10

12

Trade and other receivables

1,061

965

Derivative financial instruments

75

96

Other current financial assets

27

19

Cash and cash equivalents

498

415

Assets classified as held for sale

1

25

Current assets

2,401

2,115

TOTAL ASSETS

4,626

4,478

* Unaudited



Liabilities and shareholders’ equity

(in millions of euros)

AtSeptember 30, 2008(*)

AtDecember 31, 2007

Share capital

1,213

1,204

Additional paid-in capital

138

147

Other reserves

89

123

Deficit

(1,704)

(1,863)

Equity deficit attributable to equity holders of Rhodia S.A.

(264)

(389)

Minority interests

21

21

Total equity deficit

(243)

(368)

Borrowings

1,643

1,675

Retirement benefits and similar obligations

1,076

1,154

Provisions

282

318

Deferred tax liabilities

44

43

Other non-current liabilities

37

29

Non-current liabilities

3,082

3,219

Borrowings

333

243

Derivative financial instruments

106

68

Retirement benefits and similar obligations

89

92

Provisions

150

138

Income tax payable

18

8

Trade and other payables

1,091

1,071

Liabilities associated with assets classified as held for sale

-

7

Current liabilities

1,787

1,627

TOTAL EQUITY AND LIABILITIES

4,626

4,478

* Unaudited



Consolidated statements of cash flows as of September 30, 2008

Quarterended

September 30, (*)

Nine monthsendedSeptember 30, (*)

(in millions of euros)

2008

2007

2008

2007

Net Profit/(loss) attributable to equity holders of RhodiaS.A.

56

45

133

107

Adjustments for :

Minority interests

-

(1)

1

1

Depreciation, amortization and impairment of non-current assets

79

75

222

220

Net increase/(decrease) in provisions and employee benefits

(3)

(28)

(40)

(47)

Net increase/(decrease) in financial provisions

-

(2)

-

(1)

Share of profit/(loss) of associates

-

-

(1)

-

Other income and expense

12

9

34

52

(Gain)/loss on disposal of non-current assets

(70)

(1)

(68)

(104)

Deferred tax expense/(income)

10

8

12

18

Foreign exchange losses/(gains)

5

1

29

7

Cash flow from operating activities before changes in working capital

89

106

322

253

Changes in working capital

- (Increase)/decrease in inventories

(88)

5

(180)

16

- (Increase)/decrease in trade and other receivables

15

(1)

(77)

10

- Increase/(decrease) in trade and other payables

(37)

17

17

(83)

- (Increase)/decrease in other current assets and liabilities

23

14

(4)

(5)

Net cash from operating activities before margin call

2

141

78

191

Margin call (1)

8

(5)

8

19

Net cash from operating activities

10

136

86

210

Purchases of property, plant and equipment

(63)

(69)

(174)

(199)

Purchases of other non-current assets

(8)

(14)

(35)

(42)

Proceeds on disposal of entities, net of cash transferred, and non-current assets

215

(4)

213

265

Purchase of entities, net of cash acquired

-

(17)

-

(17)

(Purchases of)/repayments of loans and financial investments

(7)

-

(3)

(1)

Net cash from / (used by) investing activities

137

(104)

1

6

Proceeds from issue of shares, net of costs

-

(1)

-

(1)

Dividends paid

(2)

-

(27)

(3)

New non-current borrowings, net of costs

3

1

3

632

Repayments of non-current borrowings, net of costs

(4)

(5)

(12)

(911)

Net increase/(decrease) in current borrowings

(30)

(32)

33

(40)

Net cash from / (used by) financing activities

(33)

(37)

(3)

(323)

Effect of foreign exchange rate changes

(3)

(6)

(1)

1

Net increase/(decrease) in cash and cash equivalents

111

(11)

83

(106)

Cash and cash equivalents at the beginning of the period

387

372

415

467

Cash and cash equivalents at the end of the period

498

361

498

361

* Unaudited

(1) The margin call agreements are standardised credit risk reduction contracts, which are concluded with the clearing house of an organised market or bilaterally by private contract with a counterparty